3 Dirt Cheap Stocks to Buy Right Now

By most metrics, the stock market is priced at a premium these days. But that doesn't mean bargains can't still be found.Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and Pfizer (NYSE: PFE).Prosper Junior Bakiny (CRISPR Therapeutics): Valuing relatively small biotech companies that generate little-to-no revenue is not an exact science. Even so, CRISPR Therapeutics, a gene-editing specialist, looks cheap at its current levels. CRISPR Therapeutics' market cap is $4.2 billion despite the recent approval of Casgevy, a treatment for two blood-related diseases it developed in collaboration with Vertex Pharmaceuticals.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool